TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | 1 | 0 | 3 | 6 | 11 | 26 | 8 |
S | %wins | 50 | 50 | 25 | 25 | 50 | 33 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/11 16:55 | 5/16/11 | MRX | Medicis Pharmaceutical Corp | DE | Health | Drug | Pharmaceutical Preparations | Prygocki Mark A Sr | AZ | O | P | S.d | -2,485 | 36.76 | 33 | -68 | -19 | 282 | D | 138 | 55 | 33 | 29 | 6 | 2 | -5 | -4 | 0 | -2 | -2 | -1 | -4 | |
8/16/10 16:55 | 8/12/10 | MRX | Medicis Pharmaceutical Corp | DE | Health | Drug | Pharmaceutical Preparations | Prygocki Mark A Sr | AZ | O | P | S.d | -3,021 | 26.27 | 33 | -115 | -32 | 246 | D | 31 | 48 | 20 | 11 | 21 | 1 | 3 | -5 | 1 | 1 | 9 | 5 | 5 | 38 |
5/19/09 14:23 | 5/15/09 | MRX | Medicis Pharmaceutical Corp | DE | Health | Drug | Pharmaceutical Preparations | Prygocki Mark A Sr | AZ | O | EVP,COO | S.d | -164 | 15.01 | 17 | -11 | -4 | 234 | D | -53 | -31 | 28 | 27 | 25 | 18 | 0 | 5 | 2 | -1 | 2 | 10 | 53 | 53 |
2/12/04 13:11 | 2/10/04 | MRX | Medicis Pharmaceutical Corp | DE | Health | Drug | Pharmaceutical Preparations | Prygocki Mark A Sr | AZ | O | CFO,EVP, | S.d | -4,448 | 38.40 | 33 | -116 | -88 | 15 | D | 38 | 66 | 35 | 20 | 8 | 2 | 5 | 0 | 0 | 3 | 1 | 11 | -12 | -12 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |